Paper Review Records
All Paper Review Records
21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
55
days
Efficacy and safety of golimumab biosimilar BAT2506 in patients with active psoriatic arthritis after switching from reference golimumab: 52-week results of a phase 3, double-blind, randomized study
Authors
Honghu Tang; Eva Dokoupilova; Bogdan Batko; Marek Zawadzki; Anastas Batalov; Yi Liu; Xiaolei Yang; Yinbo Zhou; Qingfeng Dong; Yi LiuShow moreShow less
Affiliations
1. West China Hospital of Sichuan University; 2. Medical Plus, s.r.o; 3. Malopolskie Badania Kliniczne Sp. z o.o; 4. Reum-Medica S. C. Bozena Kowalewska, Marek Zawadzki; 5. University Hospital “Kaspela”, Medical University of Plovdiv; 6. Bio-Thera Solutions LtdShow moreShow less
118
days
Beyond the first switch: multiple switching, cross-switching, and nocebo-aware implementation of biosimilars in real-world care in non-US health systems
Authors
Ahmad Z. Al Meslamani; Anan S. Jarab; Husam El Sharu; Khadeijah Ahmed Al MarshoodiShow moreShow less
Affiliations
1. Al Ain University; 2. Jordan University of Science and Technology; 3. Case Western Reserve University; 4. University of SharjahShow moreShow less
145
days
Exploring the potential benefits of allergen immunotherapy beyond respiratory allergy
Authors
Simone Foti Randazzese; Salvatore Barberi; Riccardo Castagnoli; Francesco Catamerò; Lorenzo Cosmi; Sara Guiducci; Lorenzo Lodi; Francesca Mori; Ivan Taietti; Sara Manti; Mattia GiovanniniShow moreShow less
Affiliations
1. University of Pavia; 2. Fondazione IRCCS Policlinico San Matteo; 3. ASST-Rhodense, RHO; 4. Meyer Children’s Hospital IRCCS; 5. University of Florence; 6. University of MessinaShow moreShow less
54
days
Combining biological matrices with growth factor concentrates: toward standardized protocols in regenerative medicine
Authors
Eduardo Anitua; María Troya; Roberto Tierno; Francisco Muruzabal; Mohammad H. AlkhraisatShow moreShow less
Affiliations
1. BTI-Biotechnology Institute; 2. University Institute for Regenerative Medicine & Oral Implantology, UIRMI (UPV/EHU-Fundación Eduardo Anitua); 3. University of JordanShow moreShow less
87
days
Expanding indications of immune checkpoint inhibitors: a decade of success going strong
Authors
Victor M. Samperio; Ruba Alchaikh Hassan; Aishwarya Ghonge; Constantin A. DasanuShow moreShow less
Affiliations
1. Eisenhower Health; 2. Christus HealthShow moreShow less
44
days
Is incretin therapy the missing link to silencing residual inflammation in biologic-treated psoriasis?
Authors
Eva Klara Merzel Šabović; Miodrag JanićShow moreShow less
Affiliations
1. University Medical Centre Ljubljana; 2. University of LjubljanaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
